$JZZI News : Based on Latest Research, JZZ Technol
Post# of 42223
New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm
West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line.
The new research focuses on the body's negative reaction to viruses, such as the SARS-2 virus among others. International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products.
https://finance.yahoo.com/news/based-latest-r...00498.html